Royalty Report: Medical, Device, Surgical – Collection: 375426


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 7


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 7

Primary Industries

  • Medical
  • Device
  • Surgical
  • Ophthalmological
  • Therapeutic
  • Radiation
  • Laser

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 375426

License Grant
The Licensee acquired certain intellectual property from an undisclosed Licensor to be used in the development of the ALLY Adaptive Cataract Treatment System.
License Property
ALLY Adaptive Cataract Treatment System is designed to combine our existing femtosecond laser technology with enhanced capabilities and a phacoemulsification system into a single unit and allow surgeons to perform each of the critical steps in a cataract procedure in a single operating room using this device.
Field of Use
The rights acquired are for laser technology in a device used by medical surgeons in a cataract procedure.

IPSCIO Record ID: 28761

License Grant
The Company has a License Agreement with the Licensor regarding the DRTS platform.
License Property
The technology is a laser targeting system or the Dual Radiation Targeting System (DRTS) to both reduce radiation exposure and improve accuracy of interventional procedures.

Their invention, called the DRTSâ„¢ Platform (Dual Radiation Targeting System), is a laser targeting system for fluoroscopically guided procedures. It allows the surgeon to use a fluoroscope to visualize and locate a deep structure, turn off the X-ray radiation, and still have accurate guidance and position information to complete the procedure. In addition to increasing surgical accuracy, the system significantly reduces time in the operating room, as well as radiation exposure for operating room personnel and patients.

IPSCIO Record ID: 2681

License Grant
The Licensee entered into a settlement Agreement with the Licensor, an individual, for the dismissal of a lawsuit. Under the terms of the settlement Agreement, the Licensee agree to provide the Licensor with the exclusive right over a three-year period to market and sell our Photon(TM) laser system and its components, including the inventory and intellectual property rights. If Dr. Spadafora is successful in finding a prospective purchaser to acquire the Photon(TM) laser system upon terms acceptable to us, we agree to pay him a commission equal to a percentage of the total purchase price. If the purchase price for the Photon(TM) laser system includes a royalty or other payments payable to us on later sales of the Photon(TM) laser system other than its hand piece component, we agree to pay Dr. Spadafora a percentage of such royalties or other payments on such later sales through the full term of the purchase Agreement. We further agree that if a purchase price includes a royalty or other payments payable to us on later sales of the hand piece component of the Photon(TM) laser system, we agree to pay Dr. Spadafora a percentage of such royalties or other payments through the full term of the purchase Agreement. Additionally, the settlement Agreement provides that if we are successful through our sole efforts, without any assistance from Dr. Spadafora, in finding a purchaser to acquire the Photon(TM) laser system or its components during the second or third year of Dr. Spadafora's exclusive rights, we agree to pay Dr. Spadafora a commission equal to a percentage of the total purchase price and of our royalties or other payments on subsequent sales of the Photon(TM) laser system or its components through the full term of the purchase Agreement. Finally, the settlement Agreement provides for mutual releases by Dr. Spadafora and us for the benefit of each other, and that we each agree to pay our own costs, expenses and attorney's fees incurred in connection with the lawsuit and the preparation of the settlement.
Field of Use
The Licensee has developed the Photon(TM) laser system, a laser cataract surgery system using a unique patented probe for minimally invasive cataract treatment, which the Licensee markets as the next generation of cataract removal based on United States Patent No. 6,454,763.

IPSCIO Record ID: 118680

License Grant
Licensor granted us a non-exclusive license to its patent covering excimer laser ablation of tissue.  The terms of the license permit us to sublicense our subsidiaries.
License Property
The excimer laser systems and related products are used to perform procedures that correct common refractive vision disorders such as nearsightedness, farsightedness and astigmatism.
Field of Use
Laser vision correction is a surgical procedure for correcting disorders such as nearsightedness, farsightedness and astigmatism using an excimer laser. This procedure uses ultraviolet laser energy to remove tissue from the surface of, and thus sculpt, the cornea into a predetermined shape. Because the excimer laser is a cold laser, it is possible to ablate, or remove precise amounts of corneal tissue without causing thermal damage to surrounding tissue. The goal of laser vision correction is to eliminate or reduce a persons reliance on corrective eyewear.

IPSCIO Record ID: 177272

License Grant
The Company acquired a Centralized Airborne Evacuation System.
License Property
The purchase includes the technical rights, patents and documentation.

Centralized airborne evacuation systems designed for evacuating laser smoke, orthopaedic bone dust (wet and dry), and electrocautery smoke from medical procedure rooms.

Field of Use
The Buyer manufactures, distributes and services surgical laser equipment.

IPSCIO Record ID: 158782

License Grant
Pursuant to a prior employment agreement, the Licensor, of Japan and residing in the U.S. and the Licensee have a contractual agreement for patents.
License Property
The patents are for Contact Laser(TM) Probes and Scalpels and Contact Fibers, Heraeus LaserBlade(TM) Scalpels and Contact Fibers, HSI conical contact fibers.

'Contact Laser(TM) Patents' means the following three U.S. Patent Nos. 4,693,244; 4,592,353; and 4,736,743.

Field of Use
Licensee's Contact Laser(TM) System, unlike conventional laser systems, enables the surgeon to use the laser instrument in direct contact with the tissue being treated, thereby significantly enhancing the ease of use and precision of laser surgery in many applications.

IPSCIO Record ID: 1975

License Grant
The Company licensed it intellectual laser properties; patented ultrafast laser systems for the treatment of a broad range of eye disorders.
License Property
Licensor’s solid-state pico-second (one trillionth of a second) Nd YLF (NeodymiumYitrium-Lithium-Fluoride) laser systems are designed to be more precise than lasers systems utilizing currently available technologies.
Field of Use
The rights granted apply to the healthcare market specializing in ophthalmic medical devices.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.